October 2024
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.
27 Prime Day Toy Deals On Stuff Our Kids Love (2024)
Now is the best time to snag the Lego set or board game of your kid’s holiday dreams with our favorite Prime Day toy deals.
Joe Biden’s revenge
Vice President Kamala Harris is continuing her tour of sex podcasts, leftist late-night hosts, and other friendly media, but one famous Democrat might be wavering in his support: Joe Biden himself. That’s half a joke, but there is something to it. The current Oval Office occupant is still very much alive — and still feels…
Verstappen applies to trademark “simply lovely” radio catchphrase | Formula 1
Max Verstappen has applied to trademark his “simply lovely” radio catchphrase to use it for a clothing range.
Shanahan provides CMC, Pearsall updates ahead of 49ers’ Week 6 game
Kyle Shanahan provided injury updates on Christian McCaffrey and a number of injured star San Francisco 49ers players.
Florida Hospitals and Nursing Homes Are Bracing for Hurricane Milton
More than 200 health care facilities in impacted areas are moving patients and residents in what the state’s chief of emergency medical oversight calls “our largest evacuation ever.”
Colapinto interview: “I know what I can do, I was expecting to be quick”
Franco Colapinto has surprised the outside world with his impressive Formula 1 performances for Williams since an unexpected Monza debut. But himself? Not so much.Colapinto was dropped into the Williams to replace the struggling Logan Sargeant from September’s Italian Grand Prix onwards. At the time questions were raised over whether the Argentinian F2 prospect was…
Blaze News original: One company’s pet project: Build a future for lab-grown meat
The “cultivated meat” industry appears to be experiencing serious growing pains. The sector that once had investors salivating now faces significant technological, financial, and legal challenges — as well as the ever-present fear that consumers just won’t bite. ‘The same people who are doomsaying it now were hyping it five years ago.’ While American players…